Uses
Dextrose and Sodium Chloride Injection is indicated as a source of water, electrolytes, and calories in adults and pediatric patients.
Source: US FDA prescribing information
Fixed-dose combination
Dextrose, unspecified form and Sodium chloride is a fixed-dose combination medicine indicated as a source of water, electrolytes, and calories in adults and pediatric patients. MedsAcross supplies Dextrose, unspecified form and Sodium chloride for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
Dextrose and Sodium Chloride Injection is indicated as a source of water, electrolytes, and calories in adults and pediatric patients.
Source: US FDA prescribing information
Dextrose is a source of carbohydrate calories and is used to supplement nutrition by providing glucose parenterally. Sodium Chloride restores and maintains extracellular fluid volume and osmolality, while supporting membrane potential, nerve and muscle function, and acid-base balance.
Source: US FDA prescribing information
Only for intravenous infusion. Infusion rate depends on the age, weight, clinical, and metabolic conditions of the patient and concomitant therapy. See full prescribing information for more information on preparation, administration, and dosing considerations.
Source: US FDA prescribing information
Dextrose and Sodium Chloride Injection is contraindicated in patients with: Known hypersensitivity to dextrose and/or sodium chloride Clinically significant hyperglycemia Known hypersensitivity to dextrose or sodium chloride. Clinically significant hyperglycemia
Source: US FDA prescribing information
Neonatal Hypoglycemia: Closely monitor blood glucose concentration to ensure adequate glycemic control. Hypersensitivity Reactions: Monitor for signs and symptoms and discontinue infusion immediately if reaction occurs. Hyperglycemia and Hyperosmolar Hyperglycemic State: Use with caution in patients with known subclinical or overt diabetes mellitus. Hyponatremia, Hypokalemia, Hypernatremia and Hyperchloremia: Avoid in patients with or at risk for hypo-/hypernatremia and hypokalemia. If use cannot be avoided, monitor serum sodium and potassium concentrations. Fluid Overload: Avoid in patients with or at risk for fluid and/or solute overloading. If use cannot be avoided, monitor daily fluid balance and electrolyte concentrations and acid-base balance, as needed and especially during prolonged use. Phlebitis and Thrombosis: Remove catheter as soon as possible if thrombophlebitis develops.
Source: US FDA prescribing information
Neonatal Hypoglycemia Hypersensitivity Hyperglycemia and Hyperosmolar Hyperglycemic State Hyponatremia Hypokalemia Hypernatremia and Hyperchloremia Fluid Overload Phlebitis and Thrombosis Refeeding syndrome The following adverse reactions associated with the use of Dextrose and Sodium Chloride Injection were identified in clinical studies or postmarketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Administration site conditions: Blister, erythema, extravasation, pain, phlebitis, vein damage, thrombosis. Immune system disorders: Anaphylaxis, angioedema, bronchospasm, chills, hypotension, pruritus, pyrexia, rash. Cardiovascular disorders: Cyanosis, volume overload.
Source: US FDA prescribing information
Effects on Glycemic Control, Vasopressin, Fluid, and Electrolyte Balance: Monitor blood glucose concentrations, fluid balance, serum electrolyte concentrations, and acid-base balance. Lithium: Monitor serum lithium concentrations during concomitant use.
Source: US FDA prescribing information
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F). Protect from freezing.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
14 presentations of Dextrose, unspecified form and Sodium chloride, sorted by availability.
| Medicine | Active ingredient | Manufacturer | Register | Availability |
|---|---|---|---|---|
| Dextrose, unspecified form and Sodium chloride 100 g/4.5 g per 1000 mL injectionIntravenousGeneric name | Dextrose, unspecified form and Sodium chloride | — | US FDA | Available on request |
| Dextrose, unspecified form and Sodium chloride 12.5 g/0.5 g per 250 mL injectionIntravenousGeneric name | Dextrose, unspecified form and Sodium chloride | — | US FDA | Available on request |
| Dextrose, unspecified form and Sodium chloride 12.5 g/1.125 g per 250 mL injectionIntravenousGeneric name | Dextrose, unspecified form and Sodium chloride | — | US FDA | Available on request |
| Dextrose, unspecified form and Sodium chloride 16.5 g/1.5 g per 500 mL injectionIntravenousGeneric name | Dextrose, unspecified form and Sodium chloride | — | US FDA | Available on request |
| Dextrose, unspecified form and Sodium chloride 25 g/0.5 g per 250 mL injectionIntravenousGeneric name | Dextrose, unspecified form and Sodium chloride | — | US FDA | Available on request |
| Dextrose, unspecified form and Sodium chloride 25 g/1 g per 500 mL injectionIntravenousGeneric name | Dextrose, unspecified form and Sodium chloride | — | US FDA | Available on request |
| Dextrose, unspecified form and Sodium chloride 25 g/1.65 g per 500 mL injectionIntravenousGeneric name | Dextrose, unspecified form and Sodium chloride | — | US FDA | Available on request |
| Dextrose, unspecified form and Sodium chloride 25 g/2.25 g per 500 mL injectionIntravenousGeneric name | Dextrose, unspecified form and Sodium chloride | — | US FDA | Available on request |
| Dextrose, unspecified form and Sodium chloride 25 g/4.5 g per 500 mL injectionIntravenousGeneric name | Dextrose, unspecified form and Sodium chloride | — | US FDA | Available on request |
| Dextrose, unspecified form and Sodium chloride 33 g/3 g per 1000 mL injectionIntravenousGeneric name | Dextrose, unspecified form and Sodium chloride | — | US FDA | Available on request |
| Dextrose, unspecified form and Sodium chloride 50 g/2 g per 1000 mL injectionIntravenousGeneric name | Dextrose, unspecified form and Sodium chloride | — | US FDA | Available on request |
| Dextrose, unspecified form and Sodium chloride 50 g/3.3 g per 1000 mL injectionIntravenousGeneric name | Dextrose, unspecified form and Sodium chloride | — | US FDA | Available on request |
| Dextrose, unspecified form and Sodium chloride 50 g/4.5 g per 1000 mL injectionIntravenousGeneric name | Dextrose, unspecified form and Sodium chloride | — | US FDA | Available on request |
| Dextrose, unspecified form and Sodium chloride 50 g/9 g per 1000 mL injectionIntravenousGeneric name | Dextrose, unspecified form and Sodium chloride | — | US FDA | Available on request |
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | Not recorded | — |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Yes, on request. MedsAcross lists 14 presentations of Dextrose, unspecified form and Sodium chloride and sources them for licensed hospitals, importers and physicians against valid import documents.
No listed presentation of Dextrose, unspecified form and Sodium chloride is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.